查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363133

藥物動力學服務市場規模、佔有率、趨勢分析報告：按藥物類型、用途、最終用途、地區和細分市場預測，2023-2030 年

Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules), By Application (SMEs) By End-use (Biotechnology & Pharmaceutical Companies) By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

藥物動力學服務市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球藥物動力學服務市場規模將達到17.624億美元，2023年至2030年年複合成長率為7.5%。

採用藥物動力學和毒理學研究來確定一些參數，例如無觀察到效應水平（NOEL）、人體等效劑量（HED）水平以及藥物動力學/藥效學（PK/PD）促進因素正在增加，預計將推動市場成長。

徹底了解潛在候選藥物的藥物動力學特徵對於藥物研發計畫的成功起著重要作用。除此之外，法規機構透過制定明確的 PK 研究指導方針，在該市場的發展中發揮重要作用。有大量 CRO 根據相關 EMEA、ICH、FDA、GCP 和其他法規指南進行 PK 研究。

人們對在藥物開發過程中有效實施 PK 服務的興趣日益濃厚，預計將推動這一領域的投資。在世界各地舉辦了一些會議和認證課程，以提高對臨床和臨床前藥物開發中藥物動力學應用相關的各種範式的理解。

藥物動力學服務市場報告亮點

  • 以藥物類型來看，小分子在 2022 年佔據市場主導地位，收益佔有率為 76.7%，在高服務普及和學名藥日益普及的推動下，預計在預測期內將保持領先地位。
  • 由於臨床階段中存在大量生技藥品和生物相似藥，預計大分子的 PK 分析將在預測期內顯著成長。
  • 由於美國存在大量生物製藥和藥品製造營業單位，2022年北美將佔據最大佔有率。
  • 預計亞太地區在預測期內將以 9.2% 的最快年複合成長率擴張。這是因為一些國家的持續經濟成長引起了全球CRO的高度關注，導致業務擴張。
  • 主要服務提供者包括 Pharmaceutical Product Development, LLC、Charles River Laboratories International, Inc.、PAREXEL International Corporation 和 Eurofins Scientific, Inc.。
  • 這些CRO正在採取各種配合措施來開拓新的市場途徑並增加未來的市場佔有率。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 藥物動力學服務市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 藥物動力學服務市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 藥物動力學服務市場：按藥物類型估計和趨勢分析

  • 藥物動力學服務市場重點
  • 藥物動力學服務市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 低分子
  • 聚合物（生物製藥）

第5章 藥物動力學服務市場：按用途估計和趨勢分析

  • 藥物動力學服務市場重點
  • 藥物動力學服務市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 中小企業
  • 主要企業

第6章 藥物動力學服務市場：最終用途的估計和趨勢分析

  • 藥物動力學服務市場重點
  • 藥物動力學服務市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 生物技術和製藥公司
  • 學術和政府研究機構
  • 其他

第7章 藥物動力學服務市場：區域估計與趨勢分析

  • 區域預測
  • 按地區分類的藥物動力學服務市場：重點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Evotec AG
    • Certara, LP
    • Pacific BioLabs
    • GVK Biosciences Private Limited
    • Shanghai Medicilon Inc.
    • Pharmaceutical Product Development, LLC
    • Charles River Laboratories International, Inc.
    • PAREXEL International Corporation
    • Eurofins Scientific, Inc.
    • Frontage Labs
    • SGS SA
    • LGC Limited
    • Creative Bioarray
Product Code: GVR-2-68038-375-1

Pharmacokinetics Services Market Growth & Trends:

The global pharmacokinetics services market size is expected to reach USD 1,762.4 million by 2030, registering a CAGR of 7.5% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Rising adoption of pharmacokinetic and toxicology studies for determination of several parameters such as no-observed-effect levels (NOEL), human equivalent doses (HED) levels, and pharmacokinetic/pharmacodynamic (PK/PD) drivers are expected to fuel market growth.

Thorough understanding of the pharmacokinetic profile of a potential drug candidate plays a major role in the success of a drug discovery program. In addition to this, regulatory bodies have played a major role in the progress of this market through establishing defined guidelines for conducting PK studies. There are a substantial number of CROs engaged in conducting PK studies in accordance with relevant EMEA, ICH, FDA, GCP, and other regulatory guidelines.

Growing concern for effective implementation of PK services in the drug development process is anticipated to drive investments in this sector. Several conferences and certification courses are being conducted across the world to increase the understanding of various paradigms associated with pharmacokinetics application in clinical and preclinical drug development.

Pharmacokinetics Services Market Report Highlights:

  • Based on drug type, Small molecule dominated the market with a revenue share of 76.7% in 2022 and is expected to maintain its lead during the forecast period fueled by high service penetration and growing popularity of generics
  • PK analysis for large molecules are expected to grow significantly during the forecast period, driven by presence of significant number of biologics and biosimilars in the clinical development phase
  • Presence of a large number of biopharmaceutical and pharmaceutical manufacturing entities in U.S. has resulted in North America accounting for the largest share in 2022
  • Asia Pacific is estimated to expand at the fastest CAGR of 9.2% over the forecast period thanks to constant economic growth in several countries, which has attracted significant attention from global CROs and resulted in business expansions
  • Pharmaceutical Product Development, LLC; Charles River Laboratories International, Inc.; PAREXEL International Corporation; and Eurofins Scientific, Inc. are some of the key service providers
  • These CROs are undertaking various initiatives in order to capitalize on new market avenues and enhance their share in the future market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Drug Type
    • 1.1.2. Application
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Drug Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmacokinetic Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Pharmacokinetic Services Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Pharmacokinetic Services Market: Drug Type Estimates & Trend Analysis

  • 4.1. Pharmacokinetic Services Market, Key Takeaways
  • 4.2. Pharmacokinetic Services Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Small Molecule
    • 4.3.1. Small molecule market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Large Molecules (Biopharmaceuticals)
    • 4.4.1. Large molecule (biopharmaceuticals) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Pharmacokinetic Services Market: Application Estimates & Trend Analysis

  • 5.1. Pharmacokinetic Services Market, Key Takeaways
  • 5.2. Pharmacokinetic Services Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Small and Medium Enterprise
    • 5.3.1. Small and medium enterprise market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Large Enterprise
    • 5.4.1. Large enterprise market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Pharmacokinetic Services Market: End Use Estimates & Trend Analysis

  • 6.1. Pharmacokinetic Services Market, Key Takeaways
  • 6.2. Pharmacokinetic Services Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Biotechnology & Pharmaceutical Companies
    • 6.3.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Academic & Government Research Institutes
    • 6.4.1. Academic & government research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Pharmacokinetic Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Pharmacokinetic Services Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Evotec AG
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Certara, L.P.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Pacific BioLabs
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. GVK Biosciences Private Limited
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Shanghai Medicilon Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Pharmaceutical Product Development, LLC
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Charles River Laboratories International, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. PAREXEL International Corporation
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Eurofins Scientific, Inc.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Frontage Labs
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. SGS SA
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. LGC Limited
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. Creative Bioarray
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 3 North America pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America pharmacokinetic services market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 7 U.S. pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 10 Canada pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 13 Europe pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe pharmacokinetic services market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 17 Germany pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 20 UK pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 23 France pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 24 France pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 26 Italy pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 29 Spain pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 32 Denmark pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 35 Sweden pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 38 Norway pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific pharmacokinetic services market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 45 Japan pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 48 China pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 49 China pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 51 India pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 52 India pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 54 Australia pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 57 Thailand pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 60 South Korea pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 63 Latin America pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America pharmacokinetic services market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 67 Brazil pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 70 Mexico pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 73 Argentina pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa pharmacokinetic services market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 80 South Africa pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 86 UAE pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait pharmacokinetic services market, by drug type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait pharmacokinetic services market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait pharmacokinetic services market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Pharmacokinetic services: Market outlook
  • Fig. 9 Pharmacokinetic services Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Pharmacokinetic services market driver impact
  • Fig. 15 Pharmacokinetic services market restraint impact
  • Fig. 16 Pharmacokinetic services market strategic initiatives analysis
  • Fig. 17 Pharmacokinetic services market: Drug type movement analysis
  • Fig. 18 Pharmacokinetic services market: Drug type outlook and key takeaways
  • Fig. 19 Small molecules market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Large molecules (biopharmaceuticals) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Pharmacokinetic services market: Application movement analysis
  • Fig. 22 Pharmacokinetic services market: Application outlook and key takeaways
  • Fig. 23 Small and medium enterprise market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Large enterprise market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmacokinetic services market: End use movement analysis
  • Fig. 26 Pharmacokinetic services market: End use outlook and key takeaways
  • Fig. 27 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Academic & government research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Global pharmacokinetic services market: Regional movement analysis
  • Fig. 31 Global pharmacokinetic services market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)